의약품 관련 법령
Guide: Substantial Amendments to the Clinical Research Development Dossier for Medicinal Products (DDCM) and to the Clinical Trial Protocol, Suspensions and Cancellations, 16-Aug-2018 (Fourth Edition)
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-08-20 | 조회수 | 803 |
국가정보 | 남 아메리카>브라질 | ||
출처 | ANVISA | ||
원문 | http://portal.anvisa.gov.br/ | ||
첨부파일 |
Guide: Substantial Amendments to the Clinical Research Development Dossier for Medicinal Products (DDCM) and to the Clinical Trial Protocol, Suspensions and Cancellations(Fourth Edition)
- 이전글 BfArM FAQs: on Summaries of Risk Management Plans
- 다음글 Evaluation Report: Drug Not Approval Document of CLORIDRATO DE FEXOFENADINA (Fexofenadine hydrochloride)